ArticleMicrosystems & nanoengineering2026
Photoacoustic microscopy reveals deep angiogenic responses in 3D bioprinted tumor-vessel models.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Three-dimensional (3D) tumor-vessel models provide a physiologically relevant platform to study tumor-induced angiogenesis and evaluate therapeutic responses. However, imaging-based analysis of these models is often constrained by limited penetration depth and volumetric resolution. To overcome these challenges, we employed high-resolution photoacoustic microscopy (HR - PAM) to monitor and quantify angiogenesis within bioprinted tumor-vessel models under drug treatments. Compared to confocal microscopy, the PAM achieved a 1.6-fold increase in 1/e² penetration depth, enabling visualization of vascular structures up to ~1 mm in depth. Using our HR - PAM platform, we successfully monitored and quantified tumor-induced angiogenesis, and following treatment with antibiotics, observed significant suppression. This deep tissue and large-volume PAM platform provides enhanced 3D insights into the effects of antibiotics on angiogenesis, paving the way for more precise in vitro evaluations of therapeutic interventions and drug screening studies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.